Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03042858Active Not Recruiting

Natural History of Infants With Patent Processus Vaginalis

Role: collaborator

NCT02271932Unknown

Multi-institutional Trial of Non-operative Management of Appendicitis

Role: collaborator

NCT02349178Phase 2Terminated

Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT

Role: collaborator

All 3 trials loaded